(Q50597206)

16 March 2018

title

A dose-effect correlation for radioiodine ablation in differentiated thyroid cancer. (English)

1 reference

16 March 2018

Glenn D Flux

1

0 references

author name string

Masud Haq

2

1 reference

16 March 2018

Sarah J Chittenden

3

1 reference

16 March 2018

Susan Buckley

4

1 reference

16 March 2018

Cecilia Hindorf

5

1 reference

16 March 2018

Kate Newbold

6

1 reference

16 March 2018

Clive L Harmer

7

1 reference

16 March 2018

publication date

4 September 2009

1 reference

16 March 2018

number of pages

6

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

16 March 2018

volume

37

1 reference

16 March 2018

issue

2

1 reference

16 March 2018

page(s)

270-275

1 reference

16 March 2018

https://scigraph.springernature.com/pub.10.1007/s00259-009-1261-3

exact match

0 references

cites work

Optimization of equipment and methodology for whole body activity retention measurements in children undergoing targeted radionuclide therapy.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-009-1261-3

Guidelines for radioiodine therapy of differentiated thyroid cancer

21 January 2018

1 reference

12 December 2020

Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal

1 reference

12 December 2020

Improved prediction of therapeutic absorbed doses of radioiodine in the treatment of thyroid carcinoma

1 reference

12 December 2020

Update: the case for patient-specific dosimetry in radionuclide therapy

1 reference

12 December 2020

Accurate dosimetry in 131I radionuclide therapy using patient-specific, 3-dimensional methods for SPECT reconstruction and absorbed dose calculation

1 reference

12 December 2020

Iodine-131 treatment of thyroid cancer: absorbed dose calculated from post-therapy scans

1 reference

12 December 2020

Second primary malignancies in thyroid cancer patients

1 reference

12 December 2020

The HiLo trial: a multicentre randomised trial of high- versus low-dose radioiodine, with or without recombinant human thyroid stimulating hormone, for remnant ablation after surgery for differentiated thyroid cancer

1 reference

12 December 2020

Management guidelines for patients with thyroid nodules and differentiated thyroid cancer

1 reference

12 December 2020

EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry I: blood and bone marrow dosimetry in differentiated thyroid cancer therapy.

1 reference

12 December 2020

Radiation dose assessment in radioiodine therapy. Dose-response relationships in differentiated thyroid carcinoma using quantitative scanning and PET.

1 reference

12 December 2020

European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium

1 reference

12 December 2020

Dosimetry-guided radioactive iodine treatment in patients with metastatic differentiated thyroid cancer: largest safe dose using a risk-adapted approach

1 reference

12 December 2020

Impact of 131I diagnostic activities on the biokinetics of thyroid remnants.

1 reference

12 December 2020

131I activity for remnant ablation in patients with differentiated thyroid cancer: A systematic review

1 reference

12 December 2020

Estimation and implications of random errors in whole-body dosimetry for targeted radionuclide therapy.

1 reference

12 December 2020

Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software

1 reference

12 December 2020

Dosimetric considerations in the radioiodine treatment of macrometastases and micrometastases from differentiated thyroid cancer

1 reference

12 December 2020

The so-called stunning of thyroid tissue

1 reference

12 December 2020

Salivary gland toxicity after radioiodine therapy for thyroid cancer

1 reference

12 December 2020

Dosimetry for Fractionated 131I-mIBG Therapies in Patients with Primary Resistant High-Risk Neuroblastoma: Preliminary Results

1 reference

12 December 2020

Determination of protein-bound radioiodine with an anion exchange resin

1 reference

12 December 2020

The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer

1 reference

12 December 2020

Value of protein-bound radioactive iodine measurements in the management of differentiated thyroid cancer treated with (131)I

1 reference

12 December 2020

10.1007/S00259-009-1261-3

Identifiers

DOI

1 reference

16 March 2018

1 reference

16 March 2018